It has been previously shown that a combination of a different EZH2 inhibitor, EPZ-6438, was synergistic with glucocorticoid receptor agonists such as prednisolone and dexamethasone in B cell lymphoma [34]. The gene discussed is EZH2; the disease is B-cell non-Hodgkin lymphoma.